Diversified Enterprises’s Novo Nordisk NVO Stock Holding History

Diversified Enterprises’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$446K	Buy	9,295 +1,382	+17%	+$59.4K	0.02%	261
2026 Q1	$291K	Buy	7,913 +11	+0.1%	+$521	0.02%	326
2025 Q4	$402K	Buy	7,902 +1,386	+21%	+$70.9K	0.02%	249
2025 Q3	$362K	Sell	6,516 -2,191	-25%	-$128K	0.02%	209
2025 Q2	$601K	Buy	8,707 +638	+8%	+$43.4K	0.04%	140
2025 Q1	$560K	Buy	8,069 +1,681	+26%	+$139K	0.05%	148
2024 Q4	$549K	Buy	6,388 +172	+3%	+$18.6K	0.05%	120
2024 Q3	$740K	Buy	+6,216	New	+$829K	0.08%	94

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Diversified Enterprises's NVO Position: Q2 2026 in Review

Diversified Enterprises increased its Novo Nordisk (NVO) stake by 17% in Q2 2026, buying an estimated $59.4K and bringing the position to 9,295 shares worth $446K. The position accounts for 0.02% of the portfolio, ranked #261.

Diversified Enterprises first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $740K in Q3 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Diversified Enterprises held 9,295 shares of Novo Nordisk worth $446K as of Q2 2026.
Diversified Enterprises bought 1,382 Novo Nordisk shares in Q2 2026, an estimated $59.4K.
Novo Nordisk made up 0.02% of Diversified Enterprises's portfolio in Q2 2026, its #261 holding.
Diversified Enterprises first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Diversified Enterprises's Novo Nordisk position peaked at $740K in Q3 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.